Notably, plasma p‐tau217 demonstrated a strong capacity for differentiating between Aβ/tau stages; abnormal plasma GFAP appeared to facilitate Aβ‐induced tau progression, whereas plasma NfL wa more closely associated with non‐AD‐specific neuronal injury and cognitive decline. This evidence concerns the gene GFAP and Alzheimer disease.